Simvastatin Inhibits the Malignant Behaviors of Gastric Cancer Cells by Simultaneously Suppressing YAP and β-Catenin Signaling.
Qing LiuHongwei XiaSheng ZhouQiulin TangJitao ZhouMin RenFeng BiPublished in: OncoTargets and therapy (2020)
Statins represent a promising therapeutic option for gastric cancer by simultaneously targeting YAP and β-catenin signaling.